NDC 43742-1396

Virus Plus

Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode

Virus Plus is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Deseret Biologicals, Inc.. The primary component is Influenza A Virus A/singapore/gp1908/2015 Ivr-180 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/singapore/infimh-16-0019/2016 Nib-104 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated); Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Adenovirus B Serotype 7 Strain 55142 Antigen; Human Herpesvirus 1; Human Herpesvirus 2; Human Herpesvirus 5; Human Herpesvirus 4; Hepatitis B Virus; Norwalk Virus.

Product ID43742-1396_a2ca13d3-8bf0-449f-b589-ad4f38872bef
NDC43742-1396
Product TypeHuman Otc Drug
Proprietary NameVirus Plus
Generic NameInfluenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2018-11-02
Marketing End Date2023-12-10
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameDeseret Biologicals, Inc.
Substance NameINFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 NIB-104 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 4; HEPATITIS B VIRUS; NORWALK VIRUS
Active Ingredient Strength12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL
NDC Exclude FlagN

Packaging

NDC 43742-1396-1

30 mL in 1 BOTTLE, DROPPER (43742-1396-1)
Marketing Start Date2018-11-02
Marketing End Date2023-12-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43742-1396-1 [43742139601]

Virus Plus LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-11-02
Marketing End Date2023-12-10

Drug Details

Active Ingredients

IngredientStrength
INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]/mL

OpenFDA Data

SPL SET ID:ad0b66c0-8b9d-4bbd-b205-a873ff565d50
Manufacturer
UNII

NDC Crossover Matching brand name "Virus Plus" or generic name "Influenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode"

NDCBrand NameGeneric Name
43742-0397Virus PlusInfluenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode
43742-0539Virus PlusInfluenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode
43742-0559Virus PlusInfluenzinum, Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus
43742-0736Virus PlusInfluenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-0807Virus PlusInfluenzinum (2015-2016), Adenoviren Nosode, Herpes Simplex 1, Herpes Simplex 2, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-0960Virus PlusInfluenzinum (2016-2017), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-1117Virus PlusInfluenzinum (2017-2018), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-1396Virus PlusInfluenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode
43742-1415Virus CombinationInfluenzinum (2018-2019), Adenoviren Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Cytomegalovirus Nosode, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Norovirus Nosode

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.